Woman Man
- | Country :
- Switzerland
- Sweden
- France
- ...
- | organs : -
- | Specialty : -
Extract
The primary objective of the study is to assess the activity of XRP9881 in combination with trastuzumab. The secondary objectives are safety and pharmacokinetic interaction
Inclusion criteria
- Breast Neoplasms